Abstract
Early-onset sepsis (EOS) remains a major cause of neonatal morbidity and mortality. Even in the era of universal group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis, EOS due to GBS and gram-negatives such as Escherichia coli is common. Both maternal and neonatal risk factors can be used to guide decisions regarding diagnostic evaluations and empiric antibiotic therapy for EOS. Prevention can be optimized by providing adequate prenatal care, reducing preterm deliveries, and providing intrapartum antibiotic prophylaxis when warranted.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–80.
Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013.
Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E coli disease continues. Pediatrics. 2011;127:817–26.
Higgins RD, Saade G, Polin RA, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127:426–36.
Wortham JM, Hansen NI, Schrag SJ, et al. Chorioamnionitis and culture-confirmed, early-onset neonatal infections. Pediatrics. 2016;137:e20152323.
Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.
Weintraub AS, Cadet CT, Perez R, et al. Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology. 2013;103:235–40.
Shani L, Weitzman D, Melamed R, et al. Risk factors for early sepsis in very low birth weight neonates with respiratory distress syndrome. Acta Paediatr. 2008;97:12–5.
Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol. 2006;26:677–81.
Polin RA. Committee on fetus and newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.
Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics. 2017;140:e2017044.
Lu Q, Zhou M, Tu Y, Yao Y, Yu J, Cheng S. Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014. J Paediatr Child Health. 2016;52:939–43.
Bizzaro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121:689–96.
Heideking M, Lander F, Hufnagel M, et al. Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-10. Eur J Clin Microbiol Infect Dis. 2013;32:1221–3.
Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO’s currently recommended antibiotics – systematic review and meta-analysis. Arch Dis Child. 2013;98:146–54.
Greenhow TL, Cantey JB. The disputed champion: ampicillin and gentamicin for febrile young infants. Hosp Pediatr. 2017; Available online Jul 20 2017.
Johnson SJ, Ernst EJ, Moores KG. Is double coverage of gram-negative organisms necessary? Am J Heatlh Syst Pharm. 2011;68:119–24.
Stockmann C, Spigarelli MG, Campbell SC, et al. Considerations in the pharmacologic treatment and prevention of neonatal sepsis. Pediatr Drugs. 2014;16:67–81.
Mohan P, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database Syst Rev. 2003;4:CD003956.
INIS Collaborative Group, Brocklehurst P, Farrell B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011;265:1201–11.
Pammi M, Haque KN. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev. 2015;3:CD004205.
Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicenter, randomised controlled trial. Lancet. 2009;373:226–33.
Clifford V, Garland SM, Grimwood K. Prevention of neonatal group B streptococcus disease in the 21st century. J Paediatr Child Health. 2012;48:808–15.
Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P. Missed opportunities for preventing group B streptococcus infection. Arch Dis Child Fetal Neonatal Ed. 2010;95:F72–3.
Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360:2626–36.
Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann. 1993;22:711–4.
Vekemans J, Moorthy V, Friede M, et al. Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 2018; Available online Feb 2 2018.
Shapiro-Mendoza CK, Barfield WD, Henderson Z, et al. CDC grand rounds: public health strategies to prevent preterm birth. MMWR Morb Mortal Wkly Rep. 2016;65:826–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Lee, S.A. (2018). Early-Onset Sepsis. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90038-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90037-7
Online ISBN: 978-3-319-90038-4
eBook Packages: MedicineMedicine (R0)